Is the number of TACE treatments in HCC patients associated with improved survival? A SEER-Medicare population analysis.


210 Background: We examine treatment patterns and associated survival outcomes of TACE at all stages of Hepatocellular Carcinoma in SEER Medicare. METHODS Medicare enrollees, 65 and older, with a diagnosis of a primary HCC between 2000-07 who received treatment were followed through end of 2009 using the Surveillance, Epidemiology and End-Results Program… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.